OyaGen: OyaGen reports progress in fight against virus

OyaGen Inc., a local biotechnology company, and the National Institute of Allergy and Infectious Diseases' Integrated Research Facility at Fort Detrick, Md., have found compound OYA1 to be antiviral for the coronavirus. SARS-CoV-2 is the leading agent for COVID-19, or coronavirus, and the two organizations discovered that OYA1 is dose-dependently antiviral based on cell culture infectivity ...